LYNOZYFIC

LINVOSELTAMAB-GCPT · Regeneron Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LYNOZYFIC, covering 2025-07-02 to 2026-07-31. Get the full timeline:

Most recent: FDA Approved: LYNOZYFIC — Supplemental Application (RENGENERON PHARMACEUTICALS, INC.)